Frontiers in Immunology (Jul 2018)

Adipocytes Promote Early Steps of Breast Cancer Cell Dissemination via Interleukin-8

  • Gabriela Vazquez Rodriguez,
  • Gabriela Vazquez Rodriguez,
  • Annelie Abrahamsson,
  • Annelie Abrahamsson,
  • Lasse Dahl Ejby Jensen,
  • Charlotta Dabrosin,
  • Charlotta Dabrosin

DOI
https://doi.org/10.3389/fimmu.2018.01767
Journal volume & issue
Vol. 9

Abstract

Read online

Fat is a major tissue component in human breast cancer (BC). Whether breast adipocytes (BAd) affect early stages of BC metastasis is yet unknown. BC progression is dependent on angiogenesis and inflammation, and interleukin-8 (IL-8) and vascular endothelial growth factor (VEGF) are key regulators of these events. Here, we show that BAd increased the dissemination of estrogen receptor positive BC cells (BCC) in vivo in the zebrafish model of metastasis, while dissemination of the more aggressive and metastatic BCC such as estrogen receptor negative was unaffected. While anti-VEGF and anti-IL-8 exhibited equal inhibition of angiogenesis at the primary tumor site, anti-IL-8 reduced BCC dissemination whereas anti-VEGF had minor effects on this early metastatic event. Mechanistically, overexpression of cell-adhesion molecules in BCC and neutrophils via IL-8 increased the dissemination of BCC. Importantly, the extracellular in vivo levels of IL-8 were 40-fold higher than those of VEGF in human BC. Our results suggest that IL-8 is a clinical relevant and promising therapeutic target for human BC.

Keywords